{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:41:01Z","timestamp":1782780061452,"version":"3.54.5"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093996","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T18:58:21Z","timestamp":1396465101000},"page":"e93996","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Synergistic Effects of Targeted PI3K Signaling Inhibition and Chemotherapy in Liposarcoma"],"prefix":"10.1371","volume":"9","author":[{"given":"Shang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Lopez-Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Petur","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Mankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J.","family":"Hornicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell R.","family":"Borger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/CCO.0b013e32834796e6","article-title":"Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma","volume":"23","author":"AM Crago","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1245\/s10434-009-0806-9","article-title":"Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience","volume":"17","author":"RS de Vreeze","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/107327480501200102","article-title":"Diagnosis, classification, and management of soft tissue sarcomas","volume":"12","author":"HJ Mankin","year":"2005","journal-title":"Cancer Control"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4278\/ajhp.120606-QUAL-286","article-title":"Moderate to vigorous physical activity and weight outcomes: does every minute count?","volume":"28","author":"JX Fan","year":"2013","journal-title":"Am J Health Promot"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2148-13-109","article-title":"Phylogenetic analysis of symbionts in feather-feeding lice of the genus Columbicola: evidence for repeated symbiont replacements","volume":"13","author":"WA Smith","year":"2013","journal-title":"BMC Evol Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jso.20975","article-title":"Diagnosis and management of lipomatous tumors","volume":"97","author":"KM Dalal","year":"2008","journal-title":"J Surg Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/DAD.0b013e3181a129b7","article-title":"Low-fat and fat-free pleomorphic lipomas: a diagnostic challenge","volume":"31","author":"MP Sachdeva","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAP.0b013e3181bb6b86","article-title":"Fluorescence in situ hybridization in the diagnosis of soft tissue neoplasms: a review","volume":"16","author":"MR Tanas","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"ref9","first-page":"4937","article-title":"Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma","volume":"26","author":"J Segura-Sanchez","year":"2006","journal-title":"Anticancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"483154","DOI":"10.1155\/2011\/483154","article-title":"Liposarcoma: molecular genetics and therapeutics","volume":"2011","author":"R Conyers","year":"2011","journal-title":"Sarcoma"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/ijc.23380","article-title":"HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon","volume":"122","author":"A Italiano","year":"2008","journal-title":"Int J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P","article-title":"Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors","volume":"24","author":"F Pedeutour","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<531::AID-PATH579>3.0.CO;2-W","article-title":"Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours","volume":"190","author":"AP Dei Tos","year":"2000","journal-title":"J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1309\/HEF7-54YQ-JUVE-2THH","article-title":"H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis","volume":"115","author":"A Sakamoto","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s004280050255","article-title":"No correlation of c-myc overexpression and p53 mutations in liposarcomas","volume":"433","author":"R Schneider-Stock","year":"1998","journal-title":"Virchows Arch"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"16386","DOI":"10.1073\/pnas.1106127108","article-title":"Aberrant AKT activation drives well-differentiated liposarcoma","volume":"108","author":"A Gutierrez","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/modpathol.2011.148","article-title":"Involvement of the PI3K\/Akt pathway in myxoid\/round cell liposarcoma","volume":"25","author":"EG Demicco","year":"2012","journal-title":"Mod Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.ajpath.2013.01.002","article-title":"Novel dedifferentiated liposarcoma xenograft models reveal PTEN down-regulation as a malignant signature and response to PI3K pathway inhibition","volume":"182","author":"KB Smith","year":"2013","journal-title":"Am J Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/emmm.201000070","article-title":"Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine","volume":"2","author":"D Dias-Santagata","year":"2010","journal-title":"EMBO Mol Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-11-2308","article-title":"Activation of PI3K signaling in Merkel cell carcinoma","volume":"18","author":"V Nardi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2010.01.014","article-title":"Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma","volume":"293","author":"Z Duan","year":"2010","journal-title":"Cancer Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/mol.107.038117","article-title":"8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells","volume":"72","author":"Z Duan","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1158\/1078-0432.CCR-12-1157","article-title":"Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation","volume":"18","author":"Z Duan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K pathway as drug target in human cancer","volume":"28","author":"KD Courtney","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11912-012-0227-y","article-title":"PI3K and mTOR signaling pathways in cancer: new data on targeted therapies","volume":"14","author":"L Willems","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/0008-5472.CAN-06-4615","article-title":"Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases","volume":"67","author":"FI Raynaud","year":"2007","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1038\/onc.2009.215","article-title":"The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair","volume":"28","author":"MA Westhoff","year":"2009","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/modpathol.2010.208","article-title":"PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events","volume":"24","author":"L Agell","year":"2011","journal-title":"Mod Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1172\/JCI57909","article-title":"Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers","volume":"121","author":"H Ebi","year":"2011","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ng.619","article-title":"Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy","volume":"42","author":"J Barretina","year":"2010","journal-title":"Nat Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/0008-5472.CAN-10-1601","article-title":"A dual PI3K\/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models","volume":"71","author":"T Bagci-Onder","year":"2011","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1158\/1078-0432.CCR-10-2530","article-title":"Targeting aberrant PI3K\/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma","volume":"17","author":"D Opel","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref33","first-page":"1867","article-title":"Combination of PI3K\/mTOR inhibition demonstrates efficacy in human chordoma","volume":"29","author":"J Schwab","year":"2009","journal-title":"Anticancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"531958","DOI":"10.1155\/2014\/531958","article-title":"A population-based study of childhood cancer survivors\u2019 body mass index","volume":"2014","author":"EL Warner","year":"2014","journal-title":"J Cancer Epidemiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drup.2010.11.001","article-title":"New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort","volume":"14","author":"A Hoffman","year":"2011","journal-title":"Drug Resist Updat"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:04:44Z","timestamp":1565312684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093996"}},"subtitle":[],"editor":[{"given":"Jin Q.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093996","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]}}}